These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13444076)

  • 21. Mycobacterium tuberculosis virulence: lipids inside and out.
    Ehrt S; Schnappinger D
    Nat Med; 2007 Mar; 13(3):284-5. PubMed ID: 17342139
    [No Abstract]   [Full Text] [Related]  

  • 22. Genomic analysis of zinc homeostasis in Mycobacterium tuberculosis.
    Riccardi G; Milano A; Pasca MR; Nies DH
    FEMS Microbiol Lett; 2008 Oct; 287(1):1-7. PubMed ID: 18752625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analyses of Mycobacterium tuberculosis proteins.
    Larsen MH; Biermann K; Jacobs WR
    Curr Protoc Microbiol; 2007 Aug; Chapter 10():Unit 10A.4. PubMed ID: 18770605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification, crystallization and preliminary X-ray studies of Mycobacterium tuberculosis RRF.
    Saikrishnan K; Kalapala SK; Bidya Sagar M; Rao AR; Varshney U; Vijayan M
    Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):368-70. PubMed ID: 14747728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic inactivation and reactivation of chloramphenicol by Mycobacterium tuberculosis and Mycobacterium bovis.
    Sohaskey CD
    FEMS Microbiol Lett; 2004 Nov; 240(2):187-92. PubMed ID: 15522506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of a key Mycobacterium tuberculosis biosynthetic phosphoinositide intermediate.
    Jayaprakash KN; Lu J; Fraser-Reid B
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3815-9. PubMed ID: 15203168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipolytic enzymes in Mycobacterium tuberculosis.
    Côtes K; Bakala N'goma JC; Dhouib R; Douchet I; Maurin D; Carrière F; Canaan S
    Appl Microbiol Biotechnol; 2008 Apr; 78(5):741-9. PubMed ID: 18309478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental studies on Mycobacterium tuberculosis].
    Toita I
    Kekkaku; 1982 Aug; 57(8):409-17. PubMed ID: 6815366
    [No Abstract]   [Full Text] [Related]  

  • 29. IgA nephropathy associated with pleuropulmonary tuberculosis.
    Singh P; Khaira A; Sharma A; Dinda AK; Tiwari SC
    Singapore Med J; 2009 Jul; 50(7):e268-9. PubMed ID: 19644616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of Fe3+-acinetoferrin analogs as an iron source by Mycobacterium tuberculosis.
    Rodriguez GM; Gardner R; Kaur N; Phanstiel O
    Biometals; 2008 Feb; 21(1):93-103. PubMed ID: 17401548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent knowledge concerning the biochemistry of Mycobacterium tuberculosis].
    BESTA B
    Arch Tisiol Mal Appar Respir; 1958 Jun; 13(6):455-74. PubMed ID: 13572209
    [No Abstract]   [Full Text] [Related]  

  • 32. [Energy balance in growth of Mycobacterium tuberculosis H37Rv].
    HELLER J; SZAFRANSKI P; SZARKOWSKA L; SZARKOWSKI JW
    Acta Biochim Pol; 1957; 4(1):33-9. PubMed ID: 13468979
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preparation of Mycobacterium tuberculosis labeled with radiophosphorus (P32)].
    BONET-MAURY P; DESBORDES J; DEYSINE A
    C R Seances Soc Biol Fil; 1953 Jul; 147(13-14):1209-11. PubMed ID: 13127282
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of various chemicals upon oxygen consumption of the Mycobacterium tuberculosis.
    SUZUKI T
    Sci Rep Res Inst Tohoku Univ Med; 1953 Jun; 5(1):27-34. PubMed ID: 13135530
    [No Abstract]   [Full Text] [Related]  

  • 35. [Respiration of Mycobacterium tuberculosis].
    TYSAROWSKI W; KWIEK S
    Gruzlica (1926); 1954 Mar; 22(3):213-24. PubMed ID: 13183399
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of product release in NO detoxification from Mycobacterium tuberculosis truncated hemoglobin N.
    Martí MA; Bidon-Chanal A; Crespo A; Yeh SR; Guallar V; Luque FJ; Estrin DA
    J Am Chem Soc; 2008 Feb; 130(5):1688-93. PubMed ID: 18189394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
    Anishetty S; Pulimi M; Pennathur G
    Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nitrate-reducing capacity of Mycobacterium tuberculosis].
    VIRTANEN S
    Duodecim; 1956; 72(12):1016-8. PubMed ID: 13397475
    [No Abstract]   [Full Text] [Related]  

  • 39. [Electrophoretic findings on the protein composition of Mycobacterium tuberculosis].
    SALGARELLO G
    Boll Soc Ital Biol Sper; 1958 Nov; 34(22):1546-7. PubMed ID: 13607855
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaerobic arginine metabolism of Mycobacterium tuberculosis is mediated by arginine deiminase (arcA), but is not essential for chronic persistence in an aerogenic mouse model of infection.
    Sürken M; Keller C; Röhker C; Ehlers S; Bange FC
    Int J Med Microbiol; 2008 Oct; 298(7-8):657-61. PubMed ID: 18032107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.